- Home
- KNSA vs ARCB Comparison
KNSA vs ARCB Comparison
Compare KNSA & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- ARCB
- Stock Information
- Founded
- KNSA 2015
- ARCB 1923
- Country
- KNSA United Kingdom
- ARCB United States
- Employees
- KNSA N/A
- ARCB N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- ARCB Trucking Freight/Courier Services
- Sector
- KNSA Health Care
- ARCB Industrials
- Exchange
- KNSA Nasdaq
- ARCB Nasdaq
- Market Cap
- KNSA 1.9B
- ARCB 1.7B
- IPO Year
- KNSA 2018
- ARCB N/A
- Fundamental
- Price
- KNSA $35.71
- ARCB $75.70
- Analyst Decision
- KNSA Strong Buy
- ARCB Buy
- Analyst Count
- KNSA 6
- ARCB 13
- Target Price
- KNSA $40.83
- ARCB $93.50
- AVG Volume (30 Days)
- KNSA 439.9K
- ARCB 251.5K
- Earning Date
- KNSA 10-28-2025
- ARCB 10-31-2025
- Dividend Yield
- KNSA N/A
- ARCB 0.64%
- EPS Growth
- KNSA N/A
- ARCB 27.88
- EPS
- KNSA 0.07
- ARCB 6.77
- Revenue
- KNSA $529,332,000.00
- ARCB $4,054,102,000.00
- Revenue This Year
- KNSA $37.21
- ARCB N/A
- Revenue Next Year
- KNSA $11.99
- ARCB $5.58
- P/E Ratio
- KNSA $539.78
- ARCB $10.99
- Revenue Growth
- KNSA 56.18
- ARCB N/A
- 52 Week Low
- KNSA $17.82
- ARCB $55.19
- 52 Week High
- KNSA $35.82
- ARCB $123.26
- Technical
- Relative Strength Index (RSI)
- KNSA 72.49
- ARCB 53.54
- Support Level
- KNSA $33.25
- ARCB $70.40
- Resistance Level
- KNSA $34.16
- ARCB $74.74
- Average True Range (ATR)
- KNSA 0.83
- ARCB 2.66
- MACD
- KNSA 0.07
- ARCB 0.32
- Stochastic Oscillator
- KNSA 95.59
- ARCB 71.68
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About ARCB ArcBest Corporation
ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.